Adiposity is associated with anovulation independent of serum free testosterone: A prospective cohort study. Issue 2 (26th October 2020)

• Record Type: Journal Article
• Authors: Bloom, Michael S.; Perkins, Neil J.; Sjaarda, Lindsey A.; Mumford, Sunni L.; Ye, Aijun; Kim, Keewan; Kuhr, Daniel L.; Nobles, Carrie J.; Connell, Matthew T.; Schisterman, Enrique F.
• Is Part Of: Paediatric and perinatal epidemiology. Volume 35:Issue 2(2021)
• Page Start: 174
• Page End: 183
• Publication Date: 2020-10-26
• Subjects: adiposity -- anovulation -- body mass index -- female -- infertility -- obesity -- testosterone; Pediatrics -- Periodicals; Perinatology -- Periodicals; Pediatric epidemiology -- Periodicals; Infants (Newborn) -- Diseases -- Periodicals; 618.92
• DOI: 10.1111/ppe.12726
• Languages: English
• ISSNs: 0269-5022

Abstract

Abstract: Background: Obesity, a body mass index (BMI) ≥30 kg/m 2, is linked to infertility, potentially through a greater risk of anovulation due to elevated androgens. Yet, previous studies have not directly assessed the impact of adiposity, or body fat, on anovulation in the absence of clinical infertility. Objective: To characterise the associations between adiposity and anovulation among women menstruating on a regular basis. Methods: Women from the EAGeR trial (n = 1200), a randomised controlled trial of low‐dose aspirin and pregnancy loss among women trying to conceive, were used to estimate associations between adiposity and incident anovulation. Participants completed baseline questionnaires and anthropometry, and provided blood specimens. Women used fertility monitors for up to six consecutive menstrual cycles, with collection of daily first morning voids for hormone analysis in the first two menstrual cycles for prospective assessment of anovulation. Anovulation was assessed by urine pregnanediol glucuronide or luteinising hormone concentration or the fertility monitor. Weighted mixed‐effects log‐binomial regression was used to estimate associations between measures of adiposity and incident anovulation, adjusted for free (bioavailable) testosterone, anti‐Mullerian hormone (AMH), serum lipids, and demographic and life style factors. Results: 343 (28.3%) women experienced at least one anovulatory cycle. Anovulation risk was higher per kg/m 2 greater BMI (relative risk [RR] 1.03, 95% confidence interval (CI) 1.01, 1.04), cm waist circumference (RR 1.01, 95% CI 1.00, 1.02), mm subscapular skinfold (RR 1.02, 95% CI 1.01, 1.03), and mm middle upper arm circumference (RR 1.04, 95% CI 1.01, 1.06) adjusted for serum free testosterone, AMH, lipids, and other factors. Conclusions: Adiposity may be associated with anovulation through pathways other than testosterone among regularly menstruating women. This may account in part for reported associations between greater adiposity and infertility among women having menstrual cycles regularly. Understanding the association between adiposity and anovulation might lead to targeted interventions for preventing infertility.